AbbVie's $18 Billion Blowup Brings Deal Deja Vu to Some Holders

(Bloomberg) -- AbbVie Inc.’s 15% drop after announcing a deal to pay $63 billion for Botox maker Allergan Plc may bring on deja vu for some investors who are still feeling the burn from the drugmak...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.